Diabetes Mellitus and Cardiogenic Shock Complicating Acute Myocardial Infarction
- 1 July 2018
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 131 (7) , 778-786.e1
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
- Ahmanson Foundation
- Medtronic
This publication has 31 references indexed in Scilit:
- Adherence to Methodological Standards in Research Using the National Inpatient SampleJAMA, 2017
- Prevalence of and Trends in Diabetes Among Adults in the United States, 1988-2012JAMA, 2015
- Trends in Management and Outcomes of ST-Elevation Myocardial Infarction in Patients With End-Stage Renal Disease in the United StatesThe American Journal of Cardiology, 2015
- Outcomes of Medicare Beneficiaries With Heart Failure and Atrial FibrillationJACC: Heart Failure, 2014
- Relationship Between Early Physician Follow-up and 30-Day Readmission Among Medicare Beneficiaries Hospitalized for Heart FailureJAMA, 2010
- Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapyAmerican Heart Journal, 2007
- Heart Rate Variability and Heart Rate Turbulence in Patients With Type 2 Diabetes Mellitus With Versus Without Cardiac Autonomic NeuropathyThe American Journal of Cardiology, 2007
- Increased prevalence of ventricular fibrillation in patients with type 2 diabetes mellitusHeart and Vessels, 2007
- Early Revascularization and Long-term Survival in Cardiogenic Shock Complicating Acute Myocardial InfarctionJAMA, 2006
- Diabetes Mellitus and Cardiogenic Shock in Acute Myocardial InfarctionEuropean Journal of Heart Failure, 2005